Early Evaluation of the Response of Large B Cell Non Hodgkin’s Lymphoma to Chemotherapy by Positron Emission Tomography Coupled With Computed Tomography (PET/CT)
Participation in this study involves 4 PET/CT exams, which occur before the treatments
start, after the first cycle of chemotherapy, after 4 cycles of chemotherapy and then 12
weeks after the end of the treatments. The only additional test performed in this study
compared to the regular follow-up of patients that are not in this study is the PET/CT exam
after the first cycle. Your participation in this study will not affect treatment since the
results of the first PET/CT test will not be communicated. All other tests results will be
available in the medical record.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Disease free survival at 2 years
Eric Turcotte, MD, FRCPC
Principal Investigator
Centre Hospitalier Universitaire de Sherbrooke
Canada: Health Canada
CRC 05-020
NCT00256490
November 2005
November 2009
Name | Location |
---|